101. The 20/20 eye in multiple sclerosis
- Author
-
Penny A. Weiss, J I Nelson, Ronald E. Carr, Mark J. Kupersmith, and William Seiple
- Subjects
medicine.medical_specialty ,Multiple Sclerosis ,genetic structures ,media_common.quotation_subject ,Nerve fiber layer ,Vision Disorders ,Visual Acuity ,Visual evoked potentials ,Ophthalmology ,Afferent ,medicine ,Contrast (vision) ,Humans ,Optic neuritis ,Visual Pathways ,media_common ,business.industry ,Multiple sclerosis ,medicine.disease ,eye diseases ,Optic nerve pallor ,medicine.anatomical_structure ,Visual Perception ,Evoked Potentials, Visual ,Neurology (clinical) ,business ,Visual dysfunction - Abstract
Using clinical and electrophysiologic measures, we evaluated the visual pathway of patients who had multiple sclerosis, 20/20 Snellen acuity, and no history of optic neuritis. Delayed latencies were found in the transient visual evoked potentials (VEPs) of 38% of the patients, and interocular latency differences were abnormal in 67%. Contrast VEPs were abnormal in 4.6%. Psychophysical determinations of contrast sensitivity were abnormal in 78%. Only 17% of the patients had dyschrornatopsia, 36% had afferent pupillary abnormalities, and 59% had optic nerve pallor or nerve fiber layer loss. Psychophysical contrast evaluations and VEP studies were superior to other clinical evaluations in demonstrating visual dysfunction in these patients.
- Published
- 1983